A. Jeffrey Radov - Director, Biorestorative Therapies, Inc

As of August 29, 2019


What is A. Jeffrey Radov's Net Worth?

The current estimated net worth of Biorestorative Therapies, Inc's Director, A. Jeffrey Radov, is estimated to be about $59.62B . A. Jeffrey Radov owns about 24,500 units of Biorestorative Therapies, Inc common stock. In the last 8 years at Biorestorative Therapies, Inc, A. Jeffrey Radov has sold an estimated value of $0 worth.

What is A. Jeffrey Radov's Past Insider Trading?

A. Jeffrey Radov's largest purchase order was 7,500,000 units , worth over $7.5K on December 13, 2011. In total, A. Jeffrey Radov has made about 14 transactions over 8 years of their time at Biorestorative Therapies, Inc. A. Jeffrey Radov usually trades in October, December and February, with the busiest year in 2019. The most recent transaction was a purchase order of 6,000 units , worth over $1.65K on August 29, 2019.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was A. Jeffrey Radov's Salary in 2020?

As Director of Biorestorative Therapies, Inc, A. Jeffrey Radov has a total base salary of $179,172 . A. Jeffrey Radov received compensation valued at about $179,172 in 2020 after becoming Director. The vast majority of their compensation came in the form of

What is A. Jeffrey Radov's' Mailing Address?

  • Mailing address is 8 Walworth Avenue Scarsdale NY 10583 NY

Biorestorative Therapies, Inc Executive Compensation

Name
Year
Salary
Other Compensation
Total
Lance Alstodt 2020 $64,317 - $64,317
Lance Alstodt 2019 $350,000 - $350,000
Francisco Silva 2020 $207,553 - $207,553
Francisco Silva 2019 $287,500 - $287,500
Mark Weinreb 2020 $179,172 - $179,172
Mark Weinreb 2019 $369,952 $2,400 $372,352
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1505497/000102177121000049/def14a.htm

What are Biorestorative Therapies, Inc's Past Insider Trades?

Biorestorative Therapies, Inc's most recent insider trade came on June 23, 2022 by Dale Broadrick who bought 700 units worth $2.65K . In the last 11 years, insiders at Biorestorative Therapies, Inc have sold an estimated value of $19.38K and bought an estimated value of $5.41M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Francisco Silva, VP Research and Development,  Lance Alstodt, President,  and Dale Broadrick .

BioRestorative Therapies, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1